サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1388103

デュピュイトラン病市場、シェア、規模、動向、産業分析レポート：タイプ別、疾患タイプ別、最終用途別、地域別、セグメント別予測、2023年～2032年

Dupuytren Disease Market Share, Size, Trends, Industry Analysis Report, By Type ; By Disease Type ; By End-use ; By Region, And Segment Forecasts, 2023 - 2032

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デュピュイトラン病市場、シェア、規模、動向、産業分析レポート：タイプ別、疾患タイプ別、最終用途別、地域別、セグメント別予測、2023年～2032年
出版日: 2023年10月23日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris market research社の最新調査によると、デュピュイトラン病の世界市場規模は2032年までに65億2,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

デュピュイトラン病は、手のひらの組織の異常な肥厚と短縮を伴う衰弱性疾患で、指の変形をもたらします。市場の拡大予測は、この疾患に効果的に対処し治療することの重要性が認識されつつあることを示しています。デュピュイトラン病の有病率が増加の一途をたどる中、症状を効果的に緩和し、罹患者の全体的な生活の質を向上させる治療に対する需要が高まっています。このような市場の拡大は、増加する患者に対応し、患者の幸福を高めるための治療選択肢の改善が急務であることを反映しています。

最近、アダリムマブが、特に初期段階において有望かつ費用対効果の高い治療選択肢であることが、ある研究によって明らかにされました。これらの調査結果は、アダリムマブが病状を効果的に管理すると同時に、投資に見合った価値を提供することを示しています。医療従事者や患者の間でこの疾患に対する認識や知識が高まっていることと、医学研究や診断の進歩が、デュピュイトラン病治療オプション市場の拡大を後押ししています。

発見率の向上とタイムリーな介入により、効果的な治療法に対する需要が高まっています。これに対処するため、遠藤製薬は実際の患者を紹介する「Watching Education Unfold」キャンペーンを開始し、この病気に対する認識を高めることを目指しています。このイニシアチブの主な目的は、利用可能な治療オプションについて一般の人々やヘルスケアコミュニティを教育することです。このキャンペーンの結果、デュプイトラン拘縮に関する認知度が高まり、早期診断やより適切な管理につながると期待されています。

さらに、医療技術や治療方法の著しい進歩、特に注射可能なコラゲナーゼや低侵襲手術法の開拓が市場を後押ししています。承認された治療法のひとつにXiaflexがあり、数カ国でデュプイトラン拘縮に対する注射用コラゲナーゼが使用されています。このアプローチは、従来の外科的処置と比較して侵襲性の低い選択肢を提供し、その結果、患者の治療成績が向上し、回復期間が短縮されます。このような医療技術と治療法の進歩は、市場全体の拡大を支える大きな原動力となっています。

デュピュイトラン病市場レポートハイライト

II型が最も大きなシェアを占めました。

より有効性の高い治療オプションの開発により、治療分野が最大シェアを獲得

ヘルスケアインフラの充実、産学連携の強化により欧州が最大シェアを獲得

主なプレーヤーは、バイエル、ノバルティス、ファイザー、南通精華製薬、アクティーザ・ファーマシューティカル、エンド・インターナショナルなど。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のデュピュイトラン病市場に関する洞察

  • デュピュイトラン病市場- 最終用途のスナップショット
  • デュピュイトラン病市場力学
    • 促進要因と機会
      • 世界中で高齢化人口が増加
      • 調査活動の普及率の上昇
    • 抑制要因と課題
      • 認識と診断が限定的
  • PESTEL分析
  • デュピュイトラン病市場の最終使用動向
  • バリューチェーン分析
  • COVID-19感染症の影響分析

第5章 世界のデュピュイトラン病市場、タイプ別

  • 主な調査結果
  • イントロダクション
  • 診断
  • 身体検査
  • X線
  • 治療
  • 手術
  • 放射線治療
  • 針腱膜切開術
  • ステロイドショット
  • 酵素注射
  • 処理
  • 作業療法
  • その他

第6章 世界のデュピュイトラン病市場、疾患タイプ別

  • 主な調査結果
  • イントロダクション
  • タイプI
  • タイプⅡ
  • タイプⅢ

第7章 世界のデュピュイトラン病市場、最終用途別

  • 主な調査結果
  • イントロダクション
  • 病院
  • クリニック
  • 学術・研究機関
  • その他

第8章 世界のデュピュイトラン病市場、地域別

  • 主な調査結果
  • イントロダクション
    • デュピュイトラン病市場評価、地域別、2019-2032年
  • デュピュイトラン病市場-北米
    • 北米：デュピュイトラン病市場、タイプ別、2019-2032年
    • 北米：デュピュイトラン病市場、最終用途別、2019-2032年
    • 北米：デュピュイトラン病市場、疾患タイプ別、2019-2032年
    • デュピュイトラン病市場-米国
    • デュピュイトラン病市場- カナダ
  • デュピュイトラン病市場- 欧州
    • 欧州：デュピュイトラン病市場、タイプ別、2019～2032年
    • 欧州：デュピュイトラン病市場、最終用途別、2019-2032
    • 欧州：デュピュイトラン病市場、疾患タイプ別、2019～2032年
    • デュピュイトラン病市場- 英国
    • デュピュイトラン病市場- フランス
    • デュピュイトラン病市場- ドイツ
    • デュピュイトラン病市場- イタリア
    • デュピュイトラン病市場- スペイン
    • デュピュイトラン病市場- オランダ
    • デュピュイトラン病市場- ロシア
  • デュピュイトラン病市場- アジア太平洋
    • アジア太平洋：デュピュイトラン病市場、タイプ別、2019～2032年
    • アジア太平洋：デュピュイトラン病市場、最終用途別、2019～2032年
    • アジア太平洋：デュピュイトラン病市場、疾患タイプ別、2019～2032年
    • デュピュイトラン病市場- 中国
    • デュピュイトラン病市場- インド
    • デュピュイトラン病市場- マレーシア
    • デュピュイトラン病市場- 日本
    • デュピュイトラン病市場- インドネシア
    • デュピュイトラン病市場- 韓国
  • デュピュイトラン病市場-中東およびアフリカ
    • 中東およびアフリカ：デュピュイトラン病市場、タイプ別、2019～2032年
    • 中東およびアフリカ：デュピュイトラン病市場、最終用途別、2019～2032年
    • 中東およびアフリカ：デュピュイトラン病市場、疾患タイプ別、2019～2032年
    • デュピュイトラン病市場- サウジアラビア
    • デュピュイトラン病市場-UAE
    • デュピュイトラン病市場- イスラエル
    • デュピュイトラン病市場- 南アフリカ
  • デュピュイトラン病市場-ラテンアメリカ
    • ラテンアメリカ：デュピュイトラン病市場、タイプ別、2019-2032年
    • ラテンアメリカ：デュピュイトラン病市場、最終用途別、2019-2032
    • ラテンアメリカ：デュピュイトラン病市場、疾患タイプ別、2019-2032年
    • デュピュイトラン病市場- メキシコ
    • デュピュイトラン病市場- ブラジル
    • デュピュイトラン病市場- アルゼンチン

第9章 競合情勢

  • 拡張と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第10章 企業プロファイル

  • Actiza Pharmaceutical
  • AstraZeneca
  • Bayer
  • Bristol-Meyers
  • Endo International
  • Fresenius Kabi
  • GSK
  • Hikma Pharmaceuticals
  • LEO Pharma
  • Nantong Jinghua Pharmaceutical
  • Novartis
  • Pfizer
  • Spear Pharmaceuticals
図表

List of Tables

  • Table 1 Global Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 3 Global Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Dupuytren Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 7 North America: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion
  • Table 14 Europe: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 19 UK: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 22 France: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 43 China: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 46 India: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Dupuytren Disease Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Disease Type
  • Figure 7. Global Dupuytren Disease Market, by Disease Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Dupuytren Disease Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Dupuytren Disease Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 12. Dupuytren Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Dupuytren Disease Market
目次
Product Code: PM3797

The global Dupuytren disease market size is expected to reach USD 6.52 billion by 2032, according to a new study by Polaris market research. The report "Dupuytren Disease Market Share, Size, Trends, Industry Analysis Report, By Type (Diagnosis, Treatment); By Disease Type (Type I, Type II, Type III); By End-use (Hospitals, Clinics, Academic & Research Institute, Others); By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Dupuytren's disease is a debilitating condition that involves the abnormal thickening & shortening of tissue in the palm, resulting in finger deformities. The projected expansion of the market indicates a growing acknowledgment of the significance of effectively addressing and treating this condition. As the prevalence of Dupuytren's disease continues to increase, there is a rising demand for treatments that can effectively alleviate symptoms and improve the overall quality of life for affected individuals. This market expansion reflects the urgent need for improved therapeutic options to cater to the growing number of patients and enhance their well-being.

Recently, a study has highlighted adalimumab as a promising and cost-effective treatment option, especially in the early stages of the disease. These research findings indicate that adalimumab effectively manages the condition while providing good value for the investment. Growing awareness & knowledge about the disease among healthcare professionals & patients, coupled with advancements in medical research and diagnostics, are driving the expansion of the market for Dupuytren's disease treatment options.

Demand for effective treatments has risen due to improved detection rates and timely intervention. To address this, Endo Pharmaceuticals has launched the "Watching Education Unfold" campaign, which showcases real patients and seeks to raise awareness about the disease. The main objective of this initiative is to educate the public & healthcare community about the treatment options available. As a result of this campaign, it is anticipated that awareness about Dupuytren's contracture will increase, leading to earlier diagnosis and better management of the condition.

Furthermore, the market has been propelled by notable progress in medical technology and therapeutic methods, particularly the development of injectable collagenase and minimally invasive surgical techniques. One such approved treatment is Xiaflex, which employs injectable collagenase for Dupuytren's contracture in several countries. This approach provides a less invasive option compared to traditional surgical procedures, resulting in enhanced patient outcomes and faster recovery periods. These advancements in medical technology and therapeutics have emerged as major driving forces behind the overall expansion of the market.

Dupuytren Disease Market Report Highlights

Type II segment held the largest share, owing to its high prevalence, and more innovative treatment options

Treatment segment garnered the largest share, due to development of better treatment options with higher efficacy

Europe held the largest share, due to better healthcare infrastructure, strong indudtry-academia collaboration

Key players include Bayer, Novartis, Pfizer, Nantong Jinghua Pharmaceutical, Actiza Pharmaceutical, Endo International

Polaris market research has segmented the Dupuytren disease market report based on disease type, type, end use, and region:

Dupuytren Disease, Disease Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Type I
  • Type II
  • Type III

Dupuytren Disease, Type Outlook (Revenue - USD Billion, 2023 - 2032)

  • Diagnosis
  • Physical Examination
  • X-ray
  • Treatment
  • Surgery
  • Radiation Therapy
  • Needle Aponeurotomy
  • Steroid Shot
  • Enzyme Injection
  • Occupational Therapy
  • Others

Dupuytren Disease, End Use Outlook (Revenue - USD Billion, 2023 - 2032)

  • Hospitals
  • Clinics
  • Academic & Research Institute
  • Others

Dupuytren Disease, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dupuytren Disease Market Insights

  • 4.1. Dupuytren Disease Market - End Use Snapshot
  • 4.2. Dupuytren Disease Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing aging population worldwide
      • 4.2.1.2. Rising Prevalence of Research Activities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited Awareness and Diagnosis
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Dupuytren Disease Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Dupuytren Disease Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Diagnosis
    • 5.3.1. Global Dupuytren Disease Market, by Diagnosis, by Region, 2019-2032 (USD Billion)
  • 5.4. Physical Examination
    • 5.4.1. Global Dupuytren Disease Market, by Physical Examination, by Region, 2019-2032 (USD Billion)
  • 5.5. X-ray
    • 5.5.1. Global Dupuytren Disease Market, by X-ray, by Region, 2019-2032 (USD Billion)
  • 5.6. Treatment
    • 5.6.1. Global Dupuytren Disease Market, by Treatment, by Region, 2019-2032 (USD Billion)
  • 5.7. Surgery
    • 5.7.1. Global Dupuytren Disease Market, by Surgery, by Region, 2019-2032 (USD Billion)
  • 5.8. Radiation Therapy
    • 5.8.1. Global Dupuytren Disease Market, by Radiation Therapy, by Region, 2019-2032 (USD Billion)
  • 5.9. Needle Aponeurotomy
    • 5.9.1. Global Dupuytren Disease Market, by Needle Aponeurotomy, by Region, 2019-2032 (USD Billion)
  • 5.10. Steroid Shot
    • 5.10.1. Global Dupuytren Disease Market, by Steroid Shot, by Region, 2019-2032 (USD Billion)
  • 5.11. Enzyme Injection
    • 5.11.1. Global Dupuytren Disease Market, by Enzyme Injection, by Region, 2019-2032 (USD Billion)
  • 5.12. Treatment
    • 5.12.1. Global Dupuytren Disease Market, by Treatment, by Region, 2019-2032 (USD Billion)
  • 5.13. Occupational Therapy
    • 5.13.1. Global Dupuytren Disease Market, by Occupational Therapy, by Region, 2019-2032 (USD Billion)
  • 5.14. Others
    • 5.14.1. Global Dupuytren Disease Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Dupuytren Disease Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • 6.3. Type I
    • 6.3.1. Global Dupuytren Disease Market, by Type I, by Region, 2019-2032 (USD Billion)
  • 6.4. Type II
    • 6.4.1. Global Dupuytren Disease Market, by Type II, by Region, 2019-2032 (USD Billion)
  • 6.5. Type III
    • 6.5.1. Global Dupuytren Disease Market, by Type III, by Region, 2019-2032 (USD Billion)

7. Global Dupuytren Disease Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Dupuytren Disease Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Clinics
    • 7.4.1. Global Dupuytren Disease Market, by Clinics, By Region, 2019-2032 (USD Billion)
  • 7.5. Academic & Research Institute
    • 7.5.1. Global Dupuytren Disease Market, by Academic & Research Institute, By Region, 2019-2032 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Dupuytren Disease Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Dupuytren Disease Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Dupuytren Disease Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Dupuytren Disease Market - North America
    • 8.3.1. North America: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.3.4. Dupuytren Disease Market - U.S.
      • 8.3.4.1. U.S.: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.3.5. Dupuytren Disease Market - Canada
      • 8.3.5.1. Canada: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.4. Dupuytren Disease Market - Europe
    • 8.4.1. Europe: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.4. Dupuytren Disease Market - UK
      • 8.4.4.1. UK: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.5. Dupuytren Disease Market - France
      • 8.4.5.1. France: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.6. Dupuytren Disease Market - Germany
      • 8.4.6.1. Germany: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.7. Dupuytren Disease Market - Italy
      • 8.4.7.1. Italy: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.8. Dupuytren Disease Market - Spain
      • 8.4.8.1. Spain: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.9. Dupuytren Disease Market - Netherlands
      • 8.4.9.1. Netherlands: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.4.10. Dupuytren Disease Market - Russia
      • 8.4.10.1. Russia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.5. Dupuytren Disease Market - Asia Pacific
    • 8.5.1. Asia Pacific: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.4. Dupuytren Disease Market - China
      • 8.5.4.1. China: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.5. Dupuytren Disease Market - India
      • 8.5.5.1. India: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.6. Dupuytren Disease Market - Malaysia
      • 8.5.6.1. Malaysia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.7. Dupuytren Disease Market - Japan
      • 8.5.7.1. Japan: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.8. Dupuytren Disease Market - Indonesia
      • 8.5.8.1. Indonesia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.5.9. Dupuytren Disease Market - South Korea
      • 8.5.9.1. South Korea: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.6. Dupuytren Disease Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.4. Dupuytren Disease Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.5. Dupuytren Disease Market - UAE
      • 8.6.5.1. UAE: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.6. Dupuytren Disease Market - Israel
      • 8.6.6.1. Israel: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.6.7. Dupuytren Disease Market - South Africa
      • 8.6.7.1. South Africa: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
  • 8.7. Dupuytren Disease Market - Latin America
    • 8.7.1. Latin America: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.4. Dupuytren Disease Market - Mexico
      • 8.7.4.1. Mexico: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.5. Dupuytren Disease Market - Brazil
      • 8.7.5.1. Brazil: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)
    • 8.7.6. Dupuytren Disease Market - Argentina
      • 8.7.6.1. Argentina: Dupuytren Disease Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Dupuytren Disease Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Dupuytren Disease Market, by Disease Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Actiza Pharmaceutical
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2.AstraZeneca
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bayer
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bristol-Meyers
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Endo International
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Fresenius Kabi
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GSK
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Hikma Pharmaceuticals
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. LEO Pharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Nantong Jinghua Pharmaceutical
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Novartis
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Pfizer
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Spear Pharmaceuticals
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development